Dopamine transporter distribution in patients Parkinson disease of different stages detected single-photon emission computed tomography brain imaging

Neural Regeneration Research

Volumn 2, Issue 1, 2007, Pages 18-21

  Zhang, Ji Wu ^a   Zhu, Li Juan ^a   Du, Jiang Qiang ^a   Liu, Bo ^a  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Dopamine; Emission computed; Parkinson disease; Single photon; Tomography

Indexed keywords

DOPAMINE TRANSPORTER; POTASSIUM CHLORIDE; RADIOISOTOPE; [2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CAUDATE NUCLEUS; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; CORPUS STRIATUM; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; NEUROIMAGING; PARKINSON DISEASE; PROTEIN LOCALIZATION; PUTAMEN; RADIATION MEASUREMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THALAMUS;

EID: 80054900685     PISSN: 16735374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1673-5374(07)60004-8     Document Type: Article

References (23)

1. Peng CD. Recent advances of treatment for Parkinson's disease. Shiyong Yiyao Zazhi 2004;21(3):273-6
2. Liang XB, Wang XM. Research advances on the genetics of Parkinson's disease. Shengming Kexue 2000;12(1):14-7
3. Wang LZ, Zhu XZ. Molecular pathway in Parkinson disease: An update on progress. Zhongguo Yaolixue Tongbao 2004;20(10):1081-5
4. Ma Y, Gao DM. Research progress of Parkinson's disease. Jinzhou Yixueyuan Xuebao 2003;24(6):58-60
5. Chen B, Liu ZL, Wang F. The progresses in genetics research on Parkinson's disease in China. Zhonghua Shenjingke Zazhi 2005;38(3):160-4
6. Chu YX, Wang J. An analysis of the progress in Parkinson's disease. Yixue Zongshu 2006;12(18):1112-3
7. Zhang JJ, Zhao T, Chen W, et al. Value of brain SPECT-DAT imaging in diagnosis and treatment for parkinson disease. Taishan Yixueyuan Xuebao 2005;26(2):84-5
8. Hank FK, Kung MP, Seok RC, et al. Radiopharmaceuticals for single-photon emission computed tomography brain imaging. Semin Nucl Med 2003;33(1):3-9
9. Kao PF, Tzen KY, Yen TC, et al. The optimal imaging time for 99mTc-TRODAT-1 SPECT in nomal subjects and patients with Parkinson's disease. Nucl Med Commun 2001;22(2):151-4
10. Huang MS, Lin SZ, Lin JC, et al. Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging. J Nucl Med 2001;42(9):1303-10
11. Mozley PD, Schneider JS, Acton PD, et al. Binding of 99mTc-TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in health volunteers. J Nucl Med 2000;41(4):584-9
12. Mozley PD, Stubbs JB, Plossl K, et al. Biodistribution and dosimetry of TRODAT-1:A technetium-99m-Labeled tropanes for imaging dopmine transporter J Nucl Med 1998;39(12):2069-76
13. Zhang L, Tang Y, Yu SG. Incrased expression of dopamine transporter in Parkinson's disease Mice substantia nigra by electroacupuncture therapy. Chengdu Zhongyiyao Daxue Xuebao 2006;29(3):30-3
14. Cao YQ, Zhou XP, Hu XW, et al. Functional imaging of Parkinson disease after treated by deep brain stimulation of subthalamic nucleus. Di'er Junyi Daxue Xuebao 2005;26(2):175-8
15. Huang Y, Jiang XM, Li DJ, et al. Effects on electro-scalp acupuncture on cerebral dopamine transporter in patients with Parkinson's disease. Zhongguo Zhongxiyi Jiehe Zazhi 2006;26(4):303-7
16. Shi GM, Li SC, Wang ZH, et al. Altered expression of dopamine transporter in substantia nigra and striatum in postmortem human brain of Parkinson's disease. Zhonghua Shenjingke Zazhi 2005;38(8):495-7
17. Gao YC, Lin XT, Wu CY, et al. Striatal dopamine transporter, regional cerebral blood flow and glucose utilization in MPTP-induced Parkinson disease mice model. Zhonghua Heyixue Zazhi 2005;25(3):151-4
18. Hani B, Jim P, David JW, et al. Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake. Mov Disord 2000;15(2):692-8
19. Pirker W, Asenbaum S, Hauk M, et al. Imaging serotonin and dopamine transporters with 123I-β-CIT SPECT: binding kinetics and effects of normal aging. J Nucl Med 2000;41(1):36-44
20. Weng YH, Yen TC, Chen MC, et al. Sensitivity and specificity of Tc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects. J Nucl Med 2004;45(3):393-401
21. Deng HF, Hu P. Clinical application of 99TCm-TRODAT-1 SPECT imaging of dopamine transporter in monitoring the state of Parkinson's disease. He Jishu 2005;28(7):525-9
22. Dong Q, Li JP, Liu JP, et al. Correlation of striatum dopamine transporter imaging and the scores of Parkinsonian clinical scale in patients with Parkinson's disease. Linchuang Shenjingbingxue Zazhi 2005;18(3):167-9
23. Juha OR, Hanna R, Jorgen B, et al. Usefulness of a dopamine transporter PET ligand 18F-β-CFT in assessing disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 1999;67(5):737-42